CAA develops in several AD mouse models, including the Tg2576 (APP expressed under the PrP promoter)72, and J20 mouse model (APP transgenics with Swedish and Indiana mutations), particularly after 11 to 12 months of age73,74. The gene discussed is APP; the disease is Alzheimer disease.